11-13 May, London, UK
BioTrinity is the leading European Biopartnering and Investment Conference. It provides the best opportunity to meet investors, senior licensing executives from global pharma organisations and senior management of innovative drug development and platform technology companies.
Now in its 9th year, BioTrinity is expected once again to attract 1000+ delegates from over 30 countries. The new, dedicated MediTrinity stream will attract key personnel from medtech corporates and diagnostics R&D companies.
At the heart of the event are the world class speaker programme, compelling panels of experts and the powerhouse partnering system. Together with the unequalled networking opportunities for emerging companies to pitch for partners and investment, BioTrinity has become the best catalyst for business for R&D, pharma and medtech corporates:
- Discover essential trends and ideas from the key players in the pharma and investment world
- Hear insight into securing investment through venture, corporate and strategic funds from leading minds in the global life sciences investment
- Be inspired by some of pharma’s hottest dealmakers offering a fresh perspective on successful dealmaking strategies
- Take your pick of over 100 of Europe’s best life sciences R&D company showcase sessions
- Gain invaluable up-to-date advice in your choice of industry workshops
- Design your opportunities – select who you want to meet in one-to-one meetings through partneringONE®
Visit www.biotrinity.com for more information or to register.